PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Illig, D.* ; Kotlarz, D.M.

Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD.

Front. Immunol. 13:1027289 (2022)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Inflammatory bowel disease (IBD) is a multifactorial disorder triggered by imbalances of the microbiome and immune dysregulations in genetically susceptible individuals. Several mouse and human studies have demonstrated that multimeric inflammasomes are critical regulators of host defense and gut homeostasis by modulating immune responses to pathogen- or damage-associated molecular patterns. In the context of IBD, excessive production of pro-inflammatory Interleukin-1β has been detected in patient-derived intestinal tissues and correlated with the disease severity or failure to respond to anti-tumor necrosis factor therapy. Correspondingly, genome-wide association studies have suggested that single nucleotide polymorphisms in inflammasome components might be associated with risk of IBD development. The relevance of inflammasomes in controlling human intestinal homeostasis has been further exemplified by the discovery of very early onset IBD (VEO-IBD) patients with monogenic defects affecting different molecules in the complex regulatory network of inflammasome activity. This review provides an overview of known causative monogenic entities of VEO-IBD associated with altered inflammasome activity. A better understanding of the molecular mechanisms controlling inflammasomes in monogenic VEO-IBD may open novel therapeutic avenues for rare and common inflammatory diseases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
8.786
0.000
4
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Veo-ibd ; Genetics ; Immunodeficiency ; Inflammasome ; Inflammation ; Pediatrics; Nf-kappa-b; Familial Mediterranean Fever; Wiskott-aldrich-syndrome; Encoding Mevalonate Kinase; Immune Effector Mechanism; Gamma-inducing Factor; Regulatory T-cells; Nlrp3 Inflammasome; Bowel-disease; Crohns-disease
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 1664-3224
e-ISSN 1664-3224
Zeitschrift Frontiers in Immunology
Quellenangaben Band: 13, Heft: , Seiten: , Artikelnummer: 1027289 Supplement: ,
Verlag Frontiers
Verlagsort Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Translational Genomics (ITG)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-506700-001
Förderungen Care-for-Rare Foundation
Else Kroener-Fresenius-Stiftung, Helmholtz Association/Helmholtz Munich (Helmholtz Young Investigator Group)
Leona M. and Harry B. Helmsley Charitable Trust, DFG
DOI 10.3389/fimmu.2022.1027289
WOS ID 000897815600001
WOS ID WOS:000897815600001
Scopus ID 85143912360
PubMed ID 36524121
Erfassungsdatum 2022-12-20
[➜Korrektur melden]